# Repeat Injection of Cingal® for Osteoarthritis of the Knee

> **NCT02381652** · PHASE3 · COMPLETED · sponsor: **Anika Therapeutics, Inc.** · enrollment: 242 (actual)

## Conditions studied

- Osteoarthritis of the Knee

## Interventions

- **COMBINATION_PRODUCT:** Cingal
- **COMBINATION_PRODUCT:** Cingal
- **COMBINATION_PRODUCT:** Cingal

## Key facts

- **NCT ID:** NCT02381652
- **Lead sponsor:** Anika Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-04
- **Final completion:** 2015-05
- **Target enrollment:** 242 (ACTUAL)
- **Last updated:** 2022-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02381652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02381652, "Repeat Injection of Cingal® for Osteoarthritis of the Knee". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02381652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*